16 Feb 2019
Hot topics in the pharmacologic treatment after TAVI – Current concepts
Sponsored by Daiichi Sankyo
Chairpersons:
K. Hayashida, N. Tada
Summary
Consult this session to learn more about the risk of valve thrombosis, thrombo-embolic and bleeding events after TAVI and the rationale of antithrombotic treatment regimens in atrial fibrillation patients post TAVI.
Learning Objectives
- To understand the risk of valve thrombosis, thrombo-embolic and bleeding events after TAVI
- To learn about the rationale of antithrombotic treatment regimens in atrial fibrillation patients post TAVI
